These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17544290)

  • 1. Chronic lymphocytic leukemia.
    Ghia P; Ferreri AM; Caligaris-Cappio F
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
    Abbott BL
    Oncologist; 2006 Jan; 11(1):21-30. PubMed ID: 16401710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of chronic lymphocytic leukemia: an update.
    Inamdar KV; Bueso-Ramos CE
    Ann Diagn Pathol; 2007 Oct; 11(5):363-89. PubMed ID: 17870025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic lymphoid leukemia: a single disease or 2 distinct diseases?].
    Dighiero G
    Bull Acad Natl Med; 2002; 186(7):1251-66; discussion 1266-8. PubMed ID: 12669665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in chronic lymphocytic leukemia.
    Abbott BL
    Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches to chronic lymphocytic leukemia.
    Robertson LE; Keating MJ
    Tex Med; 1991 Nov; 87(11):68-74. PubMed ID: 1759245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).
    Eichhorst B; Hallek M
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):469-77. PubMed ID: 17707834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukaemia in the Bloemfontein academic hospitals.
    Nel T; Joubert G; van der Ryst E; Bester I
    Cent Afr J Med; 1998 Aug; 44(8):195-9. PubMed ID: 10101418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caring for patients with chronic lymphocytic leukemia.
    Elphee EE
    Clin J Oncol Nurs; 2008 Jun; 12(3):417-23. PubMed ID: 18515240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current guidelines in defining therapeutic strategies.
    Ferrajoli A; Keating MJ
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):881-93, ix. PubMed ID: 15325704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in chronic lymphocytic leukemia.
    Hallek M; Kuhn-Hallek I; Emmerich B
    Leukemia; 1997 Apr; 11 Suppl 2():S4-13. PubMed ID: 9178831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers].
    Evrard S; Gaussem P; Helley D; Darnige L
    Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
    Montserrat E; Bosch F; Rozman C
    J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-chronic lymphocytic leukemia: practical aspects.
    Pangalis GA; Vassilakopoulos TP; Dimopoulou MN; Siakantaris MP; Kontopidou FN; Angelopoulou MK
    Hematol Oncol; 2002 Sep; 20(3):103-46. PubMed ID: 12203655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.